Kim Christopher 4

4 · Apimeds Pharmaceuticals US, Inc. · Filed May 20, 2025

Insider Transaction Report

Form 4
Period: 2025-05-16
Kim Christopher
DirectorChairman and CMO
Transactions
  • Award

    Common Stock, par value $0.01 per share

    2025-05-16+250,000277,500 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT